Drugs / IMTOX-25
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01378871 | Sep 2010 → Jan 2013 | adult T-cell leukemia/lymphoma | Amit Verma | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IMTOX-25 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01378871 ↗ |
| Route | Intravenous | “Treatment with Imtox-25 intravenously over 4 hours every other day for 4 doses.” NCT01378871 ↗ |